EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Post-recurrence management of malignant glial brain tumors: therapeutic strategies, evidence and limitations, palliative care, terminal sedation, and end-of-life considerations

Eva María Corrales-García, Pedro David Delgado-López, Juan Manuel Sepúlveda Sánchez, Roberto Garcia Leal, Gonzalo Lendínez-Sánchez, Santiago Cabezas-Camarero, María Sánchez-Isac, María Hernández Miguel, Ana María Ruiz Moreno, José Antonio Carrillo Santos, Jerónimo González Bernal

Clinical and Translational Oncology · 2026

DOI: 10.1007/s12094-026-04401-w ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical and Translational Oncology, 2026. Verfasst von Eva María Corrales-García und 10 weiteren Autor:innen. Beteiligte Einrichtung: Servicio de Oncología Radioterápica, Hospital Universitario de Burgos, Burgos, Spain. Hauptthemen laut MEDLINE: Brain Neoplasms, Palliative Care, Neoplasm Recurrence, Local, Terminal Care. Die Arbeit nennt 154 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recurrent malignant gliomas, particularly glioblastoma, remain among the most challenging entities in neuro-oncology, with nearly universal relapse and limited survival despite aggressive multimodal upfront treatment. Management at recurrence is heterogeneous and lacks a universally accepted standard of care, reflecting modest efficacy of available therapies and marked biological divergence between primary and recurrent tumors. This review provides a comprehensive and critical synthesis of current evidence supporting active salvage strategies, including repeat surgery, reirradiation, systemic therapies, and tumor-treating fields, highlighting indications, outcomes, and limitations. Special emphasis is placed on patient selection, extent of resection, modern radiotherapy techniques, and the role of molecularly refined approaches, which benefit only small, well-defined subgroups. Given the limited survival gains achievable with oncologic treatments, the review further addresses the central role of early integrated palliative care in recurrent malignant glioma, encompassing symptom control, home-based support, advance care planning, and end-of-life decision-making. Particular attention is paid to palliative (terminal) sedation and the ethical-legal framework surrounding euthanasia and medical aid in dying, with specific reference to the Spanish context. Overall, this article aims to contextualize therapeutic decision-making within an integrated, patient-centered model that balances potential oncologic benefit with quality of life, functional preservation, and respect for patient values.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain NeoplasmsPalliative CareNeoplasm Recurrence, LocalTerminal CareGliomaHumansSalvage Therapy

Stichwörter der Autor:innen

Palliative careRecurrent glioblastomaReirradiationReoperationSalvage therapyTumor-treating fields

Autor:innen und Institutionen

  • Servicio de Oncología Radioterápica, Hospital Universitario de Burgos, Burgos, Spain.
  • Coordinadora Nacional del Foro Interterritorial de La Sociedad Española de Oncología Radioterápica (SEOR), Burgos, Spain.
  • Servicio de Neurocirugía, Hospital Universitario de Burgos, Avda Islas Baleares 3, 09006, Burgos, Spain. pedrodl@yahoo.com.
  • Instituto de Investigación Biomédica de Burgos (IBioBURGOS), Burgos, Spain. pedrodl@yahoo.com.
  • Servicio de Oncología Médica, Hospital San Chinarro, Madrid, Spain.
  • Servicio de Neurocirugía, Hospital General Universitario "Gregorio Marañón", Madrid, Spain.

Zitieren

APA

Corrales-García, E. M., Delgado-López, P. D., Sepúlveda Sánchez, J. M., Garcia Leal, R., Lendínez-Sánchez, G., Cabezas-Camarero, S., Sánchez-Isac, M., Hernández Miguel, M., Ruiz Moreno, A. M., Carrillo Santos, J. A., & González Bernal, J. (2026). Post-recurrence management of malignant glial brain tumors: therapeutic strategies, evidence and limitations, palliative care, terminal sedation, and end-of-life considerations. Clinical and Translational Oncology. https://doi.org/10.1007/s12094-026-04401-w

Vancouver

Corrales-García EM, Delgado-López PD, Sepúlveda Sánchez JM, Garcia Leal R, Lendínez-Sánchez G, Cabezas-Camarero S, et al. Post-recurrence management of malignant glial brain tumors: therapeutic strategies, evidence and limitations, palliative care, terminal sedation, and end-of-life considerations. Clinical and Translational Oncology. 2026. doi:10.1007/s12094-026-04401-w

BibTeX
@article{CorralesGarca2026,
  author = {Corrales-García, Eva María and Delgado-López, Pedro David and Sepúlveda Sánchez, Juan Manuel and Garcia Leal, Roberto and Lendínez-Sánchez, Gonzalo and Cabezas-Camarero, Santiago and Sánchez-Isac, María and Hernández Miguel, María and Ruiz Moreno, Ana María and Carrillo Santos, José Antonio and González Bernal, Jerónimo},
  title = {Post-recurrence management of malignant glial brain tumors: therapeutic strategies, evidence and limitations, palliative care, terminal sedation, and end-of-life considerations},
  journal = {Clinical and Translational Oncology},
  year = {2026},
  doi = {10.1007/s12094-026-04401-w}
}
Kostenlos starten →